About this episode

Dr. Grant Coren joins Ivanna Rosendal to discuss the balance between patient care and profit in the pharmaceutical industry.

Send us Fan Mail “Patients first” sounds simple until you follow the incentives. We’re joined by Dr Grant Coren, a genetics-trained PhD who moved from cancer research into decades of recruiting talent across the pharmaceutical industry and biotech. Together, we ask the uncomfortable question that sits under mission statements and glossy brand values: do pharma organisations truly value patients over profit, or do we build systems where profit is the only thing we reliably measure and reward?...

Explore listener stats, chart rankings, contacts and more on the Lab to Lives podcast page.